.gif){kind=small} | |
| Discipline | Alzheimer's disease, neurology |
|---|---|
| Language | English |
| Edited by | Delphine Boche, Miia Kivipelto, Charlotte Teunissen |
| Publication details | |
| History | 2009-present |
| Publisher | BioMed Central |
| Frequency | Continuous |
| Open access | Yes |
| License | Creative Commons Attribution License 4.0 |
| Impact factor | 9.0 (2022) |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Alzheimer's Res. Ther. |
| Indexing CODEN (alt) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| CODEN | ARTLCD |
| ISSN | 1758-9193 |
| LCCN | 2009243541 |
| OCLC no. | 427406256 |
| Links | |
Alzheimer's Research & Therapy is a peer-reviewed medical journal covering research on Alzheimer's disease. It is affiliated with (Alzheimer's research UK). It was established in 2009 and is published by BioMed Central. The editors-in-chief are Delphine Boche (University of Southampton), Miia Kivipelto (Karolinska Institute), and Charlotte Teunissen (Amsterdam UMC).
Abstracting and indexing
The journal is abstracted and indexed in Chemical Abstracts Service, Embase, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports the 2022 impact factor is 9.0.
References
- "Alzheimer's Research & Therapy". 2022 Journal Citation Reports (Science ed.). Clarivate. 2023 – via Web of Science.
External links
  | This article about a neurology journal is a stub. You can help Misplaced Pages by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |